Baxion
Screening
Tags
Alerts
Theme
Viking Therapeutics, Inc.
VKTX
·
NASDAQ
·
$30.80
Share Price as of 11/2
·
$4B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q3 ended 09/30/26
10/29/26
10-Q
Q2 ended 06/30/26
07/29/26
10-Q
Q1 ended 03/31/26
04/30/26
10-K
FY 2025
02/11/26
10-Q
Q3 ended 09/30/25
10/23/25
Disclosures
Filter
8-K
Current report
10/28/26
8-K
Current report
09/28/26
8-K
Current report
09/22/26
8-K
Current report
07/29/26
8-K
Current report
05/26/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
09/25/26
424B5
Prospectus supplement
09/25/26
FWP
Free writing prospectus
09/24/26
424B5
Prospectus supplement
09/23/26
424B5
Prospectus supplement
09/23/26
Proxies
Filter
DEF 14A
Definitive proxy
04/01/26
DEFA14A
Additional proxy materials
04/01/26
DEFA14A
Additional proxy materials
04/23/25
DEFR14A
Definitive proxy (revised)
04/23/25
DEF 14A
Definitive proxy
04/08/25
Ownership
Filter
Form 3
Initial insider ownership
08/07/26
Form 4
Insider transaction
08/07/26
144
Proposed sale of securities
07/29/26
144
Proposed sale of securities
07/29/26
144
Proposed sale of securities
07/29/26
Other
Filter
305B2
305B2
09/24/26
ARS
Annual report to shareholders
04/01/26
UPLOAD
Letter from the SEC
04/21/25
ARS
Annual report to shareholders
04/08/25
CORRESP
Correspondence with the SEC
04/08/25
Latest Filings
Filter
10-Q
Q3 ended 09/30/26
10/29/26
8-K
Current report
10/28/26
8-K
Current report
09/28/26
424B5
Prospectus supplement
09/25/26
424B5
Prospectus supplement
09/25/26
Ownership
Filter
Form 3
Initial insider ownership
08/07/26
Form 4
Insider transaction
08/07/26
144
Proposed sale of securities
07/29/26
144
Proposed sale of securities
07/29/26
144
Proposed sale of securities
07/29/26